BIVI (BioVie Inc) מחיר לרווח עתידי

Geopolitical tensions and logistics disruptions are hindering raw material procurement and the execution of global trials for BioVie Inc. (BIVI). The company's estimated forward P/E reflects market expectations, with the current level standing at 0.00. The research center is based in California, while drug production is delegated to external CDMO partners. Investment attractiveness relies on patents for the treatment of Alzheimer's and cirrhosis, remaining dependent on regulatory decisions.

Forward P/E determines the stock price relative to expected annual net income, allowing for an assessment of the asset's premium based on market forecasts. When analyzing the expected P/E multiple for BioVie Inc. (BIVI), investors must consider the company's high dependence on external contractors (CRO/CMO), as any outsourcing disruptions directly impact the accuracy of these earnings expectations.